电阻抗断层成像用于设定静脉-动脉体外膜氧合患者最佳呼气末正压的评估
本研究为单中心前瞻性观察性研究,纳入23例接受机械通气和静脉-动脉体外膜氧合的患者,进行呼气末正压递减试验(从20 cm H2O至5 cm H2O,每次递减5 cm H2O),同时记录临床、通气及超声参数,并回顾性分析电阻抗断层成像数据以定义最佳呼气末正压。结果显示,医生根据呼吸参数选择的最佳呼气末正压中位数为10 cm H2O,与电阻抗断层成像选择的最佳呼气末正压无差异;电阻抗断层成像显示增加呼气末正压促进腹侧肺过度膨胀,在呼气末正压20 cm H2O时最大(34% [IQR 24.5-40]),降低呼气末正压导致背侧肺塌陷(29% [IQR 21-45.8])。高胸内压对血流动力学和心脏耐受性有负面影响。结论支持电阻抗断层成像似乎可预测定义静脉-动脉体外膜氧合患者的最佳呼气末正压,并需超声心动图辅助优化血流动力学评估和管理。
要点
- 在静脉-动脉体外膜氧合机械通气患者中,医生根据呼吸参数选择的最佳呼气末正压中位数为10 cm H2O,与电阻抗断层成像选择的最佳呼气末正压无差异。
- 电阻抗断层成像显示,增加呼气末正压促进腹侧肺过度膨胀,在呼气末正压20 cm H2O时最大(34% [IQR 24.5-40])。
- 降低呼气末正压导致背侧肺塌陷(29% [IQR 21-45.8])。
- 高胸内压对血流动力学和心脏耐受性有负面影响。
- 电阻抗断层成像似乎可预测定义最佳呼气末正压,需超声心动图辅助优化血流动力学评估和管理。
适用人群与场景
- 年龄大于18岁、接受机械通气和静脉-动脉体外膜氧合的患者(n=23)。
处置流程与药物剂量
- 进行呼气末正压递减试验:从20 cm H2O至5 cm H2O,每次递减5 cm H2O,同时监测临床参数、通气参数及超声(心脏和肺部)参数,由医生根据呼吸参数选择最佳呼气末正压,再根据血流动力学和心脏耐受性调整。
研究设计与关键结果
- 研究类型:单中心前瞻性观察性研究;样本量:n=23;人群:接受机械通气和静脉-动脉体外膜氧合的成人患者;干预:呼气末正压递减试验(20-5 cm H2O,每次5 cm H2O),同时记录电阻抗断层成像数据并回顾性分析。
- 医生根据呼吸参数选择的最佳呼气末正压中位数为10 cm H2O。
- 电阻抗断层成像显示增加呼气末正压促进腹侧肺过度膨胀,在呼气末正压20 cm H2O时最大(34% [IQR 24.5-40])。
- 降低呼气末正压导致背侧肺塌陷(29% [IQR 21-45.8])。
- 医生根据呼吸参数选择的最佳呼气末正压与电阻抗断层成像选择的最佳呼气末正压无差异。
- 高胸内压对血流动力学和心脏耐受性有负面影响。
证据类型、等级与局限
- 证据类型:单中心前瞻性观察性研究;局限:原文未报告局限性。
对床旁实践的改变
- 在静脉-动脉体外膜氧合机械通气患者进行呼气末正压滴定时,电阻抗断层成像似乎可预测定义最佳呼气末正压,需超声心动图辅助优化血流动力学评估和管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Patients on venoarterial extracorporeal membrane oxygenation have many risk factors for pulmonary complications in addition to their heart failure. Optimal positive end-expiratory pressure is unknown in these patients. The aim was to evaluate the ability of electrical impedance tomography to help the physician to select the optimal positive end-expiratory pressure in venoarterial extracorporeal membrane oxygenation treated and mechanically ventilated patients during a positive end-expiratory pressure trial.
DESIGN: Observational prospective monocentric.
SETTING: University hospital.
PATIENTS: Patients (n = 23) older than 18 years old, on mechanical ventilation and venoarterial extracorporeal membrane oxygenation.
INTERVENTIONS: A decreasing positive end-expiratory pressure trial (20-5 cm H2O) in increments of 5 cm H2O was performed and monitored by a collection of clinical parameters, ventilatory and ultrasonographic (cardiac and pulmonary) to define an optimal positive end-expiratory pressure according to respiratory criteria (optimal positive end-expiratory pressure selected by physician with respiratory parameters), and then adjusted according to hemodynamic and cardiac tolerances (optimal positive end-expiratory pressure selected by physician with respiratory, hemodynamic, and echocardiographic parameters). At the same time, electrical impedance tomography data (regional distribution of ventilation, compliance, and overdistension collapse) were recorded and analyzed retrospectively to define the optimal positive end-expiratory pressure.
MEASUREMENTS AND MAIN RESULTS: The median of this optimal positive end-expiratory pressure was 10 cm H2O in our population. Electrical impedance tomography showed that increasing positive end-expiratory pressure promoted overdistention of ventral lung, maximum at positive end-expiratory pressure 20 cm H20 (34% [interquartile range, 24.5-40]). Decreasing positive end-expiratory pressure resulted in collapse of dorsal lung (29% [interquartile range, 21-45.8]). The optimal positive end-expiratory pressure selected by physician with respiratory parameters was not different from the positive end-expiratory pressure chosen by the electrical impedance tomography. However, there is a negative impact of a high level of intrathoracic pressure on hemodynamic and cardiac tolerances.
CONCLUSIONS: Our results support that electrical impedance tomography appears predictive to define optimal positive end-expiratory pressure on venoarterial extracorporeal membrane oxygenation, aided by echocardiography to optimize hemodynamic assessment and management.
参考来源
- Soulé C, Crognier L, Puel F, et al. Assessment of Electrical Impedance Tomography to Set Optimal Positive End-Expiratory Pressure for Venoarterial Extracorporeal Membrane Oxygenation-Treated Patients. Crit Care Med. 2021. PMID: 33595959. doi:10.1097/CCM.0000000000004892
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。